Skip to main content
TRT
PROVIDER
GUIDE
RESOURCE

TRT treatment options and their tradeoffs

From injections to gels, the right choice depends on clinical factors, product labeling, access, and patient preferences.

By TRT Provider Guide

Published September 1, 2026 · Last updated September 1, 2026

Medical review status: Evidence-cited educational content; not medically reviewed.

Educational resource
Evidence Cited

FDA-approved testosterone products use different routes of administration. The “best” format is not the same for everyone; product labeling, ability to use the product correctly, cost, access, and clinical monitoring all matter.

FormatPractical considerations to discuss
InjectionsAdministration training, schedule, supplies, and how levels and adverse effects are monitored.
Topical gel or solutionDaily application and the labeled risk of transfer to another person through skin contact.
Patch, nasal, oral, or implant productsProduct-specific directions, availability, local reactions or other labeled warnings, and clinician follow-up.

Use the label, not a generic protocol

Each product has FDA-approved prescribing information. Administration instructions, contraindications, warnings, and monitoring are formulation-specific. Do not switch route, alter frequency, or use another person's medication based on an online comparison.

Safety and goals

FDA-approved testosterone products have product-specific indications and prescribing information. In June 2026, FDA requested removal of the prior class labeling limitation concerning age-related hypogonadism. This did not eliminate the need for a clinical diagnosis, individualized risk assessment, monitoring, or compliance with the current label for the prescribed product. The Endocrine Society recommends against starting therapy in several situations, including near-term fertility plans. Discuss reproductive goals before treatment, because external testosterone can suppress sperm production.

Sources and limitations

This educational overview summarizes major U.S. professional and federal sources; it is not a diagnosis, treatment plan, or substitute for an individual clinician's assessment. Guidelines inform care but do not replace judgment, and product labeling, state law, insurance coverage, and telemedicine rules can change. Read the linked primary sources for their full scope and updates.

  1. FDA testosterone safety communication and labeling information
  2. Endocrine Society guideline (2018)
  3. FDA: FDA Takes Step Forward on Testosterone Therapy for Men. April 16, 2026.
  4. FDA: Testosterone Information

Ready to explore your options?

Our tool helps you narrow down the care route that fits your situation based on testing, budget, and fertility goals.

Find My TRT Path

Not sure which TRT route fits you?

Find My TRT Path